Federated Hermes
NPCE icon

Federated Hermes’s Neuropace NPCE Stock Holding History

Federated Hermes’s Portfolio NPCE Stock Details NPCE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.69K Buy
+169
New +$2.72K ﹤0.01% 1975
2024
Q2 		– Sell
-226
Closed -$2.98K – 2104
2024
Q1 		$2.98K Buy
226
+110
+95% +$1.57K ﹤0.01% 1883
2023
Q4 		$1.2K Sell
116
-308
-73% -$2.46K ﹤0.01% 1965
2023
Q3 		$4.13K Buy
+424
New +$2.48K ﹤0.01% 1907

Other funds holding NPCE

PCH
Polar Capital Holdings London, United Kingdom $42.4B AUM 181.11% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

Federated Hermes's NPCE Position: Q2 2026 in Review

Federated Hermes opened a new position in Neuropace (NPCE) in Q2 2026: 169 shares worth $2.69K. The stake represents ﹤0.01% of the portfolio and ranks #1975 among its holdings. This is a return to the name: Federated Hermes previously reported a position in NPCE as recently as Q1 2024.

Federated Hermes first reported a position in NPCE in Q3 2023 and has held it in 4 quarters since. The position peaked at $4.13K in Q3 2023. 113 funds tracked by Wall St. Rank hold NPCE as of Q2 2026.

  • Federated Hermes held 169 shares of Neuropace worth $2.69K as of Q2 2026.
  • Neuropace was a new Federated Hermes position in Q2 2026.
  • Neuropace made up ﹤0.01% of Federated Hermes's portfolio in Q2 2026, its #1975 holding.
  • Federated Hermes first reported a position in Neuropace in Q3 2023 and has held it in 4 quarters since.
  • Federated Hermes's Neuropace position peaked at $4.13K in Q3 2023.
  • 113 funds tracked by Wall St. Rank held Neuropace as of Q2 2026.

Based on Federated Hermes's 13F filing for Q2 2026, filed 12 Aug 2026.